Pharmafile Logo

Rostrum Training

Rostrum is more than just a training company. We are dedicated to the European pharmaceutical industry, and our training courses are supported by a full range of services that help people and organisations make the most of their training.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

207b Halls Road, Tilehurst, Reading, Berkshire, RG30 4PT, UK
+44 (0)118 384 2040

 Latest Content from PMHub 

Highlighting the Power of Patient-Integration

Press Releases | December 2, 2024 | Medscape Education

Advancing person-centered care is an important topic for the Medscape Oncology team, and no one knows this better than Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy for Medscape Oncology...

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

Education, AI and More at ASH 2024

Press Releases | November 25, 2024 | Medscape Education

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year's programs,...

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Press Releases | November 22, 2024 | Innovative Trials

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Genesis Research Group unveils enhanced US market access data analytics

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?

White Papers and Resources | November 19, 2024 | Mednet

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety

Insights and reflections from the Mtech Access transforming healthcare symposium

Press Releases | November 19, 2024 | Petauri Evidence

Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief Innovation Officer, Mtech Access) shares his reflections from the day.

EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it...